Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for In-process Testing for Transdermal Patches

Posted on By

SOP for In-process Testing for Transdermal Patches

Standard Operating Procedure for In-process Testing for Transdermal Patches

1) Purpose

The purpose of this SOP is to define procedures for conducting in-process testing during the manufacturing of transdermal patches to ensure product quality, consistency, and compliance with specifications.

2) Scope

This SOP applies to all in-process testing activities conducted at various stages of transdermal patch production within the facility.

3) Responsibilities

The Quality Control (QC) Department is responsible for performing in-process testing as per this SOP. Production personnel are responsible for facilitating sample collection and ensuring timely testing.

See also  SOP for Preventing Contamination in Transdermal Patches Production

4) Procedure

4.1 Sampling

  • 4.1.1 Collect representative samples of transdermal patches at specified intervals during production according to approved sampling plans.
  • 4.1.2 Ensure samples are taken in a manner that maintains product integrity and represents the entire batch.

4.2 Visual Inspection

  • 4.2.1 Inspect transdermal patches visually for characteristics such as color, size, shape, and presence of defects.
  • 4.2.2 Document any deviations from visual acceptance criteria and initiate investigation and corrective actions as needed.

4.3 Physical Testing

  • 4.3.1 Measure thickness, weight, and dimensions of transdermal patches using calibrated equipment and documented procedures.
  • 4.3.2 Record physical test results and compare against specified limits to ensure compliance with product specifications.
See also  SOP for Final Product Inspection for Transdermal Patches

4.4 Adhesion Testing

  • 4.4.1 Conduct adhesion testing to evaluate the strength and uniformity of adhesive properties
across transdermal patches.
  • 4.4.2 Perform peel adhesion and shear strength tests using validated methods and equipment.
  • 4.5 Content Uniformity

    • 4.5.1 Analyze transdermal patches for uniform distribution of active pharmaceutical ingredient (API) using validated analytical methods (e.g., chromatography).
    • 4.5.2 Calculate content uniformity based on API concentration in sampled patches and compare against acceptance criteria.

    4.6 Dissolution Testing

    • 4.6.1 Perform dissolution testing on transdermal patches to assess the release rate of API and other critical components.
    • 4.6.2 Use appropriate dissolution media and conditions as per documented procedures and regulatory requirements.

    4.7 Microbiological Testing (if applicable)

    • 4.7.1 Conduct microbiological testing on transdermal patches to verify absence of microbial contamination.
    • 4.7.2 Follow validated methods for microbial enumeration and identification, if required by product specifications.

    5) Abbreviations, if any

    SOP: Standard Operating Procedure
    QC: Quality Control
    API: Active Pharmaceutical Ingredient

    6) Documents, if any

    Sampling Plans
    Test Method Validation Reports

    7) Reference, if any

    USP General Chapters
    ICH Guidelines for Analytical Procedures

    8) SOP Version

    Version 1.0

    See also  SOP for Adhesive Consistency Testing in Transdermal Patches
    Transdermal Patches Tags:Adhesion Testing Protocol, Analytical Method Development SOP, Assay of Active Ingredient SOP, Contamination Prevention SOP, Documentation SOP, Equipment calibration SOP, Equipment Cleaning SOP, Final Product Inspection SOP, Formulation development SOP, Homogeneity Testing SOP, In-process Testing SOP, Microbial Testing SOP, Personnel Training SOP, Process Optimization SOP, Process Validation SOP, Quality Control Transdermal Patches, Raw Material Inspection SOP, Release Rate Testing SOP, Sample Collection SOP, Sterility Maintenance SOP, Storage Conditions Transdermal Patches, Thickness Testing Procedure, Transdermal Patch Manufacturing SOP, Transdermal Patch Stability Testing, Waste Handling SOP

    Post navigation

    Previous Post: SOP for Conducting Process Validation for Transdermal Patches
    Next Post: SOP for Pharmacovigilance Archiving Procedures

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version